Skip to content
Home/Companies/Pharma/OctoPlus
OC

OctoPlus

Pharma·Netherlands·Exited 2013·Held 2yr

OctoPlus is a pharma company, headquartered in Netherlands.

Entry
2011
Hold
2yr
Exit
2013
Est. EV
–

Who owns OctoPlus?

OctoPlus was owned by Generis Capital Partners through FPCI Entreprise & Croissance I (2018 vintage) from 2011 to 2013, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-29

Generis Capital Partners
Investor
Generis Capital Partners
FPCI Entreprise & Croissance I · 2018 · Growth

Key facts

HQNetherlands
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2013

More from FPCI Entreprise & Croissance I

Other portfolio companies in the same fund.

Antoli
Active
Business ServicesFrance· 2025
APEX Digital
Active
MedTechFrance· 2025
Luquet & Duranton
Active
Business ServicesFrance· 2025
Semco
Active
IndustrialsFrance· 2025
Transfert
Active
Business ServicesFrance· 2025
Act for Sport
Active
Business ServicesFrance· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings